NO20065322L - Clopidogrelsalt og polymere former derav - Google Patents

Clopidogrelsalt og polymere former derav

Info

Publication number
NO20065322L
NO20065322L NO20065322A NO20065322A NO20065322L NO 20065322 L NO20065322 L NO 20065322L NO 20065322 A NO20065322 A NO 20065322A NO 20065322 A NO20065322 A NO 20065322A NO 20065322 L NO20065322 L NO 20065322L
Authority
NO
Norway
Prior art keywords
polymeric forms
clopidogrel salt
clopidogrel
salt
dihydrotieno
Prior art date
Application number
NO20065322A
Other languages
English (en)
Norwegian (no)
Inventor
Keith Richard Lorimer
Alicia Tee Fuay Ng
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20065322L publication Critical patent/NO20065322L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20065322A 2004-04-20 2006-11-20 Clopidogrelsalt og polymere former derav NO20065322L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56379504P 2004-04-20 2004-04-20
PCT/US2005/013279 WO2005103059A1 (en) 2004-04-20 2005-04-18 Clopidogrel salt and polymorphic forms thereof

Publications (1)

Publication Number Publication Date
NO20065322L true NO20065322L (no) 2006-11-20

Family

ID=34966351

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065322A NO20065322L (no) 2004-04-20 2006-11-20 Clopidogrelsalt og polymere former derav

Country Status (20)

Country Link
US (2) US7652139B2 (de)
EP (1) EP1740594A1 (de)
JP (1) JP2007533746A (de)
KR (1) KR20070012676A (de)
CN (1) CN1997647A (de)
AU (1) AU2005236046A1 (de)
BR (1) BRPI0510008A (de)
CA (1) CA2561006A1 (de)
CR (1) CR8651A (de)
EA (1) EA010829B1 (de)
EC (1) ECSP066933A (de)
IL (1) IL178216A0 (de)
MA (1) MA28510B1 (de)
MX (1) MXPA06012128A (de)
NO (1) NO20065322L (de)
NZ (1) NZ551374A (de)
TN (1) TNSN06311A1 (de)
UA (1) UA84335C2 (de)
WO (1) WO2005103059A1 (de)
ZA (1) ZA200608035B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1732932B1 (de) * 2004-04-09 2012-03-21 Hanmi Holdings Co., Ltd. Kristallines clopidogrelnaphthalinsulfonat oder hydrat davon, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die dieses enthält
KR100945062B1 (ko) 2006-03-22 2010-03-05 한미약품 주식회사 클로피도그렐 1,5-나프탈렌디술폰산염 및 이의 수화물의제조방법
CN100396687C (zh) * 2006-05-26 2008-06-25 浙江海翔药业股份有限公司 (+)-(s-)-氯吡格雷硫酸氢盐(i型)的制备方法
US20100062066A1 (en) * 2006-11-14 2010-03-11 Acusphere, Inc Formulations of Tetrahydropyridine Antiplatelet Agents for Parenteral or Oral Administration
EP2107061A1 (de) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Herstellungsverfahren für optisch angereichertes Clopidogrel
WO2012123958A1 (en) 2011-02-14 2012-09-20 Cadila Healthcare Limited Highly pure salts of clopidogrel free of genotoxic impurities

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2425983C3 (de) 1973-06-12 1978-09-14 Toyama Chemical Co. Ltd., Tokio Sulfonsäuresalze von Acylcholinen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzung
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2779726B1 (fr) * 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
EP1467735B1 (de) * 2001-12-18 2008-12-10 Teva Pharmaceutical Industries Ltd. Polymorphe von clopidogrel-hydrogensulfat
US7074928B2 (en) * 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
HUP0200438A3 (en) * 2002-02-06 2003-10-28 Egis Gyogyszergyar Nyilvanosan Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
SE0201661D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab New salts
CZ297472B6 (cs) * 2002-08-27 2006-12-13 Zentiva, A.S. Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I
DE10305984A1 (de) * 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
DE04770646T1 (de) * 2003-04-25 2011-12-08 Cadila Healthcare Ltd. Salze von clopidogrel und herstellungsverfahren
GB0321256D0 (en) 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
GB0325603D0 (en) 2003-11-03 2003-12-10 Sandoz Ag Organic compounds
EA008972B1 (ru) 2004-01-13 2007-10-26 Зентива А.С. Новые кристаллические формы гидробромида клопидогреля и способы их получения
AU2005214469A1 (en) 2004-02-24 2005-09-01 Siegfried Generics International Ag Pharmacologically acceptable salts of clopidogrel

Also Published As

Publication number Publication date
IL178216A0 (en) 2006-12-31
JP2007533746A (ja) 2007-11-22
MA28510B1 (fr) 2007-04-03
MXPA06012128A (es) 2007-01-31
EA200601922A1 (ru) 2007-02-27
AU2005236046A1 (en) 2005-11-03
EA010829B1 (ru) 2008-12-30
ZA200608035B (en) 2008-07-30
US20070088048A1 (en) 2007-04-19
US20100227882A1 (en) 2010-09-09
WO2005103059A1 (en) 2005-11-03
TNSN06311A1 (en) 2007-12-03
EP1740594A1 (de) 2007-01-10
KR20070012676A (ko) 2007-01-26
CN1997647A (zh) 2007-07-11
NZ551374A (en) 2010-08-27
CA2561006A1 (en) 2005-11-03
ECSP066933A (es) 2006-12-20
CR8651A (es) 2007-08-28
US7652139B2 (en) 2010-01-26
UA84335C2 (ru) 2008-10-10
BRPI0510008A (pt) 2007-09-18

Similar Documents

Publication Publication Date Title
NO20065322L (no) Clopidogrelsalt og polymere former derav
BG108868A (en) Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds
HUP0301645A2 (hu) Hidropiridin-származékok savaddíciós sói, eljárás az elżállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
PL2112155T3 (pl) Wodorosiarczan (VI) 2-acetoksy-5-(α-cyklopropylokarbonylo-2-fluorobenzylo)-4,5,6,7-tetrahydrotieno[3,2-c]pirydyny i sposób jego otrzymywania
NI200800021A (es) Derivados de n - (arilalquil) - 1h - pirrolopiridin - 2 - carboxamidas, su preparación y su aplicación en terapéutica
MX2008013724A (es) Proceso para la preparacion de formas polimorficas de hidrogeno sulfato clopidrogel.
EP1651646A4 (de) Neues verfahren zur herstellung von (+)-(s)-clopidogrelbisulfat form-i
NO20065233L (no) Polymorfe former av metyl (+)-(S)-alfa-(2-klorfenyl)-6,7-dihydrotieno[3,2-C]pyndin-5(4H)acetathydrobromid, klopidrogelhydrobromid
BRPI0418726A (pt) naftalenossulfonato de clopidogrel cristalino ou hidrato do mesmo, método para sua preparação e composição farmacêutica contendo o mesmo
EA200401234A1 (ru) Способ приготовления клопидогрела
IL192825A0 (en) A PROCESS FOR THE PREPARATION OF POLYMORPH FORM I OF (S)-(+)-METHYL-ßé?- (2-CHLOROPHENYL)-6,7-DYHIDRO-THIENO-[3,2-C]PYRIDINE-5(4H)-ACETATE HYDROGEN SULFATE
WO2008107543A3 (fr) Derives de pyrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique
WO2007032023A3 (en) A process for preparation of methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h)-acetic acid methyl ester or salts thereof having higher chiral purity and products thereof
ATE550339T1 (de) Kristallines clopidogrelnaphthalinsulfonat oder hydrat davon, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die dieses enthält
ATE513834T1 (de) Verfahren zur herstellung von (s)-(+)- clopidogrelbase und deren salzen
WO2005003138A3 (en) Process for the preparation of amorphous form of a platelet aggregation inhibitor drug
WO2008108742A3 (en) Polymorphic forms of clopidogrel hydrobromide
EA201290535A1 (ru) Способ получения фармацевтических соединений и промежуточных соединений
DE602007012121D1 (de) Verbessertes verfahren zur herstellung von clopidogrel und pharmazeutisch unbedenklichen salzen davon
EA201001278A1 (ru) Способ получения оланзапина
UA86772C2 (en) Process for the preparation of the polymorph form of methyl (s)-(+)-(2-chlorophenyl)-2-(6,7-dihydro-4h-thieno[3,2-c]pyridine-5-yl-acetate hydrogensulfate
TH77765A (th) Cgrp แอนตะกอนิสต์ที่ได้รับการคัดเลือก, กระบวนการในการเตรียมสารดังกล่าว และการใช้สารดังกล่าวในรูปของสารผสมทางเภสัชกรรม
WO2008081473A3 (en) Process for preparing clopidogrel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application